Merck's venture capital arm, M Ventures, is the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany, with a dual strategic and financial focus. It invests in biotechnology and technology sectors, specifically targeting healthcare drug development, life science tools, electronics, and frontier technology & sustainability.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is seed (50% of deals).
Portfolio
2
Fund Size
$600M
Top Stage
Seed
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Pepper Bio | Seed | $6.5M | Nov 2023 |
 Medisafe | Series C | $30M | Feb 2021 |
Top Co-Investors
NFX1 shared
Human Ventures1 shared
Silverton Partners1 shared
Tensility Venture Partners1 shared
SC Ventures1 shared
Octopus Ventures1 shared
Sanofi Ventures1 shared
Alive Israel HealthTech Fund1 shared
Menora Mivtachim1 shared
Pitango HealthTech1 shared
7wireVentures1 shared
TriVentures1 shared
Qualcomm Ventures1 shared
OurCrowd1 shared
Last updated: 21 April 2026